nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Dysgeusia—Docetaxel—breast cancer	0.000747	0.000747	CcSEcCtD
Gadoteridol—Nausea—Melphalan—breast cancer	0.000742	0.000742	CcSEcCtD
Gadoteridol—Feeling abnormal—Mitoxantrone—breast cancer	0.000742	0.000742	CcSEcCtD
Gadoteridol—Feeling abnormal—Irinotecan—breast cancer	0.000742	0.000742	CcSEcCtD
Gadoteridol—Erythema—Capecitabine—breast cancer	0.000738	0.000738	CcSEcCtD
Gadoteridol—Dysphagia—Epirubicin—breast cancer	0.000738	0.000738	CcSEcCtD
Gadoteridol—Pruritus—Thiotepa—breast cancer	0.000738	0.000738	CcSEcCtD
Gadoteridol—Pain—Fluorouracil—breast cancer	0.000737	0.000737	CcSEcCtD
Gadoteridol—Anaphylactic shock—Paclitaxel—breast cancer	0.000734	0.000734	CcSEcCtD
Gadoteridol—Oedema—Paclitaxel—breast cancer	0.000734	0.000734	CcSEcCtD
Gadoteridol—Nausea—Goserelin—breast cancer	0.000724	0.000724	CcSEcCtD
Gadoteridol—Dysgeusia—Capecitabine—breast cancer	0.000723	0.000723	CcSEcCtD
Gadoteridol—Feeling abnormal—Gemcitabine—breast cancer	0.000723	0.000723	CcSEcCtD
Gadoteridol—Shock—Paclitaxel—breast cancer	0.000722	0.000722	CcSEcCtD
Gadoteridol—Dizziness—Vinorelbine—breast cancer	0.000722	0.000722	CcSEcCtD
Gadoteridol—Urticaria—Mitoxantrone—breast cancer	0.000715	0.000715	CcSEcCtD
Gadoteridol—Diarrhoea—Thiotepa—breast cancer	0.000713	0.000713	CcSEcCtD
Gadoteridol—Body temperature increased—Mitoxantrone—breast cancer	0.000712	0.000712	CcSEcCtD
Gadoteridol—Abdominal pain—Mitoxantrone—breast cancer	0.000712	0.000712	CcSEcCtD
Gadoteridol—Abdominal pain—Irinotecan—breast cancer	0.000712	0.000712	CcSEcCtD
Gadoteridol—Body temperature increased—Irinotecan—breast cancer	0.000712	0.000712	CcSEcCtD
Gadoteridol—Feeling abnormal—Fluorouracil—breast cancer	0.000711	0.000711	CcSEcCtD
Gadoteridol—Hyperhidrosis—Paclitaxel—breast cancer	0.00071	0.00071	CcSEcCtD
Gadoteridol—Vomiting—Vinorelbine—breast cancer	0.000694	0.000694	CcSEcCtD
Gadoteridol—Body temperature increased—Gemcitabine—breast cancer	0.000693	0.000693	CcSEcCtD
Gadoteridol—Tremor—Capecitabine—breast cancer	0.000692	0.000692	CcSEcCtD
Gadoteridol—Dizziness—Thiotepa—breast cancer	0.00069	0.00069	CcSEcCtD
Gadoteridol—Rash—Vinorelbine—breast cancer	0.000688	0.000688	CcSEcCtD
Gadoteridol—Dermatitis—Vinorelbine—breast cancer	0.000688	0.000688	CcSEcCtD
Gadoteridol—Hypotension—Paclitaxel—breast cancer	0.000686	0.000686	CcSEcCtD
Gadoteridol—Ill-defined disorder—Capecitabine—breast cancer	0.000685	0.000685	CcSEcCtD
Gadoteridol—Urticaria—Fluorouracil—breast cancer	0.000685	0.000685	CcSEcCtD
Gadoteridol—Headache—Vinorelbine—breast cancer	0.000684	0.000684	CcSEcCtD
Gadoteridol—Syncope—Docetaxel—breast cancer	0.000684	0.000684	CcSEcCtD
Gadoteridol—Dysphagia—Doxorubicin—breast cancer	0.000683	0.000683	CcSEcCtD
Gadoteridol—Body temperature increased—Fluorouracil—breast cancer	0.000682	0.000682	CcSEcCtD
Gadoteridol—Sweating—Methotrexate—breast cancer	0.000674	0.000674	CcSEcCtD
Gadoteridol—Loss of consciousness—Docetaxel—breast cancer	0.00067	0.00067	CcSEcCtD
Gadoteridol—Malaise—Capecitabine—breast cancer	0.000666	0.000666	CcSEcCtD
Gadoteridol—Cough—Docetaxel—breast cancer	0.000666	0.000666	CcSEcCtD
Gadoteridol—Hypersensitivity—Irinotecan—breast cancer	0.000663	0.000663	CcSEcCtD
Gadoteridol—Hypersensitivity—Mitoxantrone—breast cancer	0.000663	0.000663	CcSEcCtD
Gadoteridol—Vomiting—Thiotepa—breast cancer	0.000663	0.000663	CcSEcCtD
Gadoteridol—Syncope—Capecitabine—breast cancer	0.000662	0.000662	CcSEcCtD
Gadoteridol—Convulsion—Docetaxel—breast cancer	0.000661	0.000661	CcSEcCtD
Gadoteridol—Paraesthesia—Paclitaxel—breast cancer	0.000659	0.000659	CcSEcCtD
Gadoteridol—Hypertension—Docetaxel—breast cancer	0.000658	0.000658	CcSEcCtD
Gadoteridol—Rash—Thiotepa—breast cancer	0.000657	0.000657	CcSEcCtD
Gadoteridol—Dermatitis—Thiotepa—breast cancer	0.000657	0.000657	CcSEcCtD
Gadoteridol—Dyspnoea—Paclitaxel—breast cancer	0.000655	0.000655	CcSEcCtD
Gadoteridol—Headache—Thiotepa—breast cancer	0.000653	0.000653	CcSEcCtD
Gadoteridol—Chest pain—Docetaxel—breast cancer	0.000649	0.000649	CcSEcCtD
Gadoteridol—Loss of consciousness—Capecitabine—breast cancer	0.000649	0.000649	CcSEcCtD
Gadoteridol—Nausea—Vinorelbine—breast cancer	0.000649	0.000649	CcSEcCtD
Gadoteridol—Cough—Capecitabine—breast cancer	0.000644	0.000644	CcSEcCtD
Gadoteridol—Hypertension—Capecitabine—breast cancer	0.000638	0.000638	CcSEcCtD
Gadoteridol—Hypersensitivity—Fluorouracil—breast cancer	0.000635	0.000635	CcSEcCtD
Gadoteridol—Dry mouth—Docetaxel—breast cancer	0.000635	0.000635	CcSEcCtD
Gadoteridol—Sweating—Epirubicin—breast cancer	0.000631	0.000631	CcSEcCtD
Gadoteridol—Chest pain—Capecitabine—breast cancer	0.000629	0.000629	CcSEcCtD
Gadoteridol—Pain—Paclitaxel—breast cancer	0.000628	0.000628	CcSEcCtD
Gadoteridol—Anxiety—Capecitabine—breast cancer	0.000626	0.000626	CcSEcCtD
Gadoteridol—Anaphylactic shock—Docetaxel—breast cancer	0.000622	0.000622	CcSEcCtD
Gadoteridol—Oedema—Docetaxel—breast cancer	0.000622	0.000622	CcSEcCtD
Gadoteridol—Discomfort—Capecitabine—breast cancer	0.000621	0.000621	CcSEcCtD
Gadoteridol—Pruritus—Gemcitabine—breast cancer	0.000621	0.000621	CcSEcCtD
Gadoteridol—Nausea—Thiotepa—breast cancer	0.000619	0.000619	CcSEcCtD
Gadoteridol—Diarrhoea—Irinotecan—breast cancer	0.000616	0.000616	CcSEcCtD
Gadoteridol—Diarrhoea—Mitoxantrone—breast cancer	0.000616	0.000616	CcSEcCtD
Gadoteridol—Dry mouth—Capecitabine—breast cancer	0.000615	0.000615	CcSEcCtD
Gadoteridol—Shock—Docetaxel—breast cancer	0.000612	0.000612	CcSEcCtD
Gadoteridol—Pruritus—Fluorouracil—breast cancer	0.00061	0.00061	CcSEcCtD
Gadoteridol—Feeling abnormal—Paclitaxel—breast cancer	0.000605	0.000605	CcSEcCtD
Gadoteridol—Oedema—Capecitabine—breast cancer	0.000603	0.000603	CcSEcCtD
Gadoteridol—Bradycardia—Epirubicin—breast cancer	0.000602	0.000602	CcSEcCtD
Gadoteridol—Diarrhoea—Gemcitabine—breast cancer	0.0006	0.0006	CcSEcCtD
Gadoteridol—Dizziness—Irinotecan—breast cancer	0.000595	0.000595	CcSEcCtD
Gadoteridol—Shock—Capecitabine—breast cancer	0.000593	0.000593	CcSEcCtD
Gadoteridol—Rhinitis—Epirubicin—breast cancer	0.000592	0.000592	CcSEcCtD
Gadoteridol—Diarrhoea—Fluorouracil—breast cancer	0.00059	0.00059	CcSEcCtD
Gadoteridol—Tinnitus—Methotrexate—breast cancer	0.000589	0.000589	CcSEcCtD
Gadoteridol—Sweating—Doxorubicin—breast cancer	0.000584	0.000584	CcSEcCtD
Gadoteridol—Urticaria—Paclitaxel—breast cancer	0.000583	0.000583	CcSEcCtD
Gadoteridol—Hyperhidrosis—Capecitabine—breast cancer	0.000583	0.000583	CcSEcCtD
Gadoteridol—Hypotension—Docetaxel—breast cancer	0.000582	0.000582	CcSEcCtD
Gadoteridol—Abdominal pain—Paclitaxel—breast cancer	0.000581	0.000581	CcSEcCtD
Gadoteridol—Body temperature increased—Paclitaxel—breast cancer	0.000581	0.000581	CcSEcCtD
Gadoteridol—Vomiting—Mitoxantrone—breast cancer	0.000573	0.000573	CcSEcCtD
Gadoteridol—Vomiting—Irinotecan—breast cancer	0.000573	0.000573	CcSEcCtD
Gadoteridol—Dizziness—Fluorouracil—breast cancer	0.00057	0.00057	CcSEcCtD
Gadoteridol—Rash—Irinotecan—breast cancer	0.000568	0.000568	CcSEcCtD
Gadoteridol—Rash—Mitoxantrone—breast cancer	0.000568	0.000568	CcSEcCtD
Gadoteridol—Dermatitis—Mitoxantrone—breast cancer	0.000567	0.000567	CcSEcCtD
Gadoteridol—Dermatitis—Irinotecan—breast cancer	0.000567	0.000567	CcSEcCtD
Gadoteridol—Headache—Irinotecan—breast cancer	0.000564	0.000564	CcSEcCtD
Gadoteridol—Headache—Mitoxantrone—breast cancer	0.000564	0.000564	CcSEcCtD
Gadoteridol—Hypotension—Capecitabine—breast cancer	0.000563	0.000563	CcSEcCtD
Gadoteridol—Paraesthesia—Docetaxel—breast cancer	0.000559	0.000559	CcSEcCtD
Gadoteridol—Vomiting—Gemcitabine—breast cancer	0.000558	0.000558	CcSEcCtD
Gadoteridol—Bradycardia—Doxorubicin—breast cancer	0.000557	0.000557	CcSEcCtD
Gadoteridol—Dyspnoea—Docetaxel—breast cancer	0.000555	0.000555	CcSEcCtD
Gadoteridol—Rash—Gemcitabine—breast cancer	0.000553	0.000553	CcSEcCtD
Gadoteridol—Dermatitis—Gemcitabine—breast cancer	0.000553	0.000553	CcSEcCtD
Gadoteridol—Tinnitus—Epirubicin—breast cancer	0.000551	0.000551	CcSEcCtD
Gadoteridol—Erythema—Methotrexate—breast cancer	0.00055	0.00055	CcSEcCtD
Gadoteridol—Headache—Gemcitabine—breast cancer	0.000549	0.000549	CcSEcCtD
Gadoteridol—Flushing—Epirubicin—breast cancer	0.000548	0.000548	CcSEcCtD
Gadoteridol—Vomiting—Fluorouracil—breast cancer	0.000548	0.000548	CcSEcCtD
Gadoteridol—Rhinitis—Doxorubicin—breast cancer	0.000548	0.000548	CcSEcCtD
Gadoteridol—Rash—Fluorouracil—breast cancer	0.000544	0.000544	CcSEcCtD
Gadoteridol—Dermatitis—Fluorouracil—breast cancer	0.000543	0.000543	CcSEcCtD
Gadoteridol—Paraesthesia—Capecitabine—breast cancer	0.000541	0.000541	CcSEcCtD
Gadoteridol—Hypersensitivity—Paclitaxel—breast cancer	0.000541	0.000541	CcSEcCtD
Gadoteridol—Headache—Fluorouracil—breast cancer	0.00054	0.00054	CcSEcCtD
Gadoteridol—Dysgeusia—Methotrexate—breast cancer	0.000538	0.000538	CcSEcCtD
Gadoteridol—Dyspnoea—Capecitabine—breast cancer	0.000537	0.000537	CcSEcCtD
Gadoteridol—Nausea—Irinotecan—breast cancer	0.000535	0.000535	CcSEcCtD
Gadoteridol—Nausea—Mitoxantrone—breast cancer	0.000535	0.000535	CcSEcCtD
Gadoteridol—Pain—Docetaxel—breast cancer	0.000532	0.000532	CcSEcCtD
Gadoteridol—Nausea—Gemcitabine—breast cancer	0.000521	0.000521	CcSEcCtD
Gadoteridol—Pruritus—Paclitaxel—breast cancer	0.00052	0.00052	CcSEcCtD
Gadoteridol—Pain—Capecitabine—breast cancer	0.000515	0.000515	CcSEcCtD
Gadoteridol—Erythema—Epirubicin—breast cancer	0.000514	0.000514	CcSEcCtD
Gadoteridol—Feeling abnormal—Docetaxel—breast cancer	0.000513	0.000513	CcSEcCtD
Gadoteridol—Nausea—Fluorouracil—breast cancer	0.000512	0.000512	CcSEcCtD
Gadoteridol—Ill-defined disorder—Methotrexate—breast cancer	0.00051	0.00051	CcSEcCtD
Gadoteridol—Tinnitus—Doxorubicin—breast cancer	0.00051	0.00051	CcSEcCtD
Gadoteridol—Flushing—Doxorubicin—breast cancer	0.000507	0.000507	CcSEcCtD
Gadoteridol—Dysgeusia—Epirubicin—breast cancer	0.000504	0.000504	CcSEcCtD
Gadoteridol—Diarrhoea—Paclitaxel—breast cancer	0.000502	0.000502	CcSEcCtD
Gadoteridol—Feeling abnormal—Capecitabine—breast cancer	0.000497	0.000497	CcSEcCtD
Gadoteridol—Malaise—Methotrexate—breast cancer	0.000496	0.000496	CcSEcCtD
Gadoteridol—Abdominal pain—Docetaxel—breast cancer	0.000492	0.000492	CcSEcCtD
Gadoteridol—Body temperature increased—Docetaxel—breast cancer	0.000492	0.000492	CcSEcCtD
Gadoteridol—Dizziness—Paclitaxel—breast cancer	0.000486	0.000486	CcSEcCtD
Gadoteridol—Cough—Methotrexate—breast cancer	0.00048	0.00048	CcSEcCtD
Gadoteridol—Urticaria—Capecitabine—breast cancer	0.000479	0.000479	CcSEcCtD
Gadoteridol—Ill-defined disorder—Epirubicin—breast cancer	0.000477	0.000477	CcSEcCtD
Gadoteridol—Body temperature increased—Capecitabine—breast cancer	0.000476	0.000476	CcSEcCtD
Gadoteridol—Abdominal pain—Capecitabine—breast cancer	0.000476	0.000476	CcSEcCtD
Gadoteridol—Convulsion—Methotrexate—breast cancer	0.000476	0.000476	CcSEcCtD
Gadoteridol—Erythema—Doxorubicin—breast cancer	0.000476	0.000476	CcSEcCtD
Gadoteridol—Chest pain—Methotrexate—breast cancer	0.000468	0.000468	CcSEcCtD
Gadoteridol—Vomiting—Paclitaxel—breast cancer	0.000467	0.000467	CcSEcCtD
Gadoteridol—Dysgeusia—Doxorubicin—breast cancer	0.000466	0.000466	CcSEcCtD
Gadoteridol—Malaise—Epirubicin—breast cancer	0.000464	0.000464	CcSEcCtD
Gadoteridol—Rash—Paclitaxel—breast cancer	0.000463	0.000463	CcSEcCtD
Gadoteridol—Dermatitis—Paclitaxel—breast cancer	0.000463	0.000463	CcSEcCtD
Gadoteridol—Discomfort—Methotrexate—breast cancer	0.000462	0.000462	CcSEcCtD
Gadoteridol—Syncope—Epirubicin—breast cancer	0.000461	0.000461	CcSEcCtD
Gadoteridol—Headache—Paclitaxel—breast cancer	0.00046	0.00046	CcSEcCtD
Gadoteridol—Hypersensitivity—Docetaxel—breast cancer	0.000459	0.000459	CcSEcCtD
Gadoteridol—Loss of consciousness—Epirubicin—breast cancer	0.000452	0.000452	CcSEcCtD
Gadoteridol—Cough—Epirubicin—breast cancer	0.000449	0.000449	CcSEcCtD
Gadoteridol—Anaphylactic shock—Methotrexate—breast cancer	0.000449	0.000449	CcSEcCtD
Gadoteridol—Convulsion—Epirubicin—breast cancer	0.000446	0.000446	CcSEcCtD
Gadoteridol—Hypertension—Epirubicin—breast cancer	0.000444	0.000444	CcSEcCtD
Gadoteridol—Hypersensitivity—Capecitabine—breast cancer	0.000444	0.000444	CcSEcCtD
Gadoteridol—Ill-defined disorder—Doxorubicin—breast cancer	0.000442	0.000442	CcSEcCtD
Gadoteridol—Pruritus—Docetaxel—breast cancer	0.00044	0.00044	CcSEcCtD
Gadoteridol—Chest pain—Epirubicin—breast cancer	0.000438	0.000438	CcSEcCtD
Gadoteridol—Anxiety—Epirubicin—breast cancer	0.000436	0.000436	CcSEcCtD
Gadoteridol—Nausea—Paclitaxel—breast cancer	0.000436	0.000436	CcSEcCtD
Gadoteridol—Hyperhidrosis—Methotrexate—breast cancer	0.000434	0.000434	CcSEcCtD
Gadoteridol—Discomfort—Epirubicin—breast cancer	0.000433	0.000433	CcSEcCtD
Gadoteridol—Malaise—Doxorubicin—breast cancer	0.000429	0.000429	CcSEcCtD
Gadoteridol—Dry mouth—Epirubicin—breast cancer	0.000428	0.000428	CcSEcCtD
Gadoteridol—Syncope—Doxorubicin—breast cancer	0.000427	0.000427	CcSEcCtD
Gadoteridol—Pruritus—Capecitabine—breast cancer	0.000426	0.000426	CcSEcCtD
Gadoteridol—Diarrhoea—Docetaxel—breast cancer	0.000426	0.000426	CcSEcCtD
Gadoteridol—Anaphylactic shock—Epirubicin—breast cancer	0.00042	0.00042	CcSEcCtD
Gadoteridol—Oedema—Epirubicin—breast cancer	0.00042	0.00042	CcSEcCtD
Gadoteridol—Hypotension—Methotrexate—breast cancer	0.000419	0.000419	CcSEcCtD
Gadoteridol—Loss of consciousness—Doxorubicin—breast cancer	0.000418	0.000418	CcSEcCtD
Gadoteridol—Cough—Doxorubicin—breast cancer	0.000415	0.000415	CcSEcCtD
Gadoteridol—Shock—Epirubicin—breast cancer	0.000413	0.000413	CcSEcCtD
Gadoteridol—Convulsion—Doxorubicin—breast cancer	0.000412	0.000412	CcSEcCtD
Gadoteridol—Diarrhoea—Capecitabine—breast cancer	0.000412	0.000412	CcSEcCtD
Gadoteridol—Dizziness—Docetaxel—breast cancer	0.000412	0.000412	CcSEcCtD
Gadoteridol—Hypertension—Doxorubicin—breast cancer	0.000411	0.000411	CcSEcCtD
Gadoteridol—Hyperhidrosis—Epirubicin—breast cancer	0.000406	0.000406	CcSEcCtD
Gadoteridol—Chest pain—Doxorubicin—breast cancer	0.000405	0.000405	CcSEcCtD
Gadoteridol—Anxiety—Doxorubicin—breast cancer	0.000404	0.000404	CcSEcCtD
Gadoteridol—Paraesthesia—Methotrexate—breast cancer	0.000403	0.000403	CcSEcCtD
Gadoteridol—Discomfort—Doxorubicin—breast cancer	0.0004	0.0004	CcSEcCtD
Gadoteridol—Dyspnoea—Methotrexate—breast cancer	0.0004	0.0004	CcSEcCtD
Gadoteridol—Dizziness—Capecitabine—breast cancer	0.000399	0.000399	CcSEcCtD
Gadoteridol—Dry mouth—Doxorubicin—breast cancer	0.000396	0.000396	CcSEcCtD
Gadoteridol—Vomiting—Docetaxel—breast cancer	0.000396	0.000396	CcSEcCtD
Gadoteridol—Rash—Docetaxel—breast cancer	0.000392	0.000392	CcSEcCtD
Gadoteridol—Hypotension—Epirubicin—breast cancer	0.000392	0.000392	CcSEcCtD
Gadoteridol—Dermatitis—Docetaxel—breast cancer	0.000392	0.000392	CcSEcCtD
Gadoteridol—Headache—Docetaxel—breast cancer	0.00039	0.00039	CcSEcCtD
Gadoteridol—Anaphylactic shock—Doxorubicin—breast cancer	0.000388	0.000388	CcSEcCtD
Gadoteridol—Oedema—Doxorubicin—breast cancer	0.000388	0.000388	CcSEcCtD
Gadoteridol—Pain—Methotrexate—breast cancer	0.000384	0.000384	CcSEcCtD
Gadoteridol—Vomiting—Capecitabine—breast cancer	0.000383	0.000383	CcSEcCtD
Gadoteridol—Shock—Doxorubicin—breast cancer	0.000382	0.000382	CcSEcCtD
Gadoteridol—Rash—Capecitabine—breast cancer	0.00038	0.00038	CcSEcCtD
Gadoteridol—Dermatitis—Capecitabine—breast cancer	0.00038	0.00038	CcSEcCtD
Gadoteridol—Headache—Capecitabine—breast cancer	0.000378	0.000378	CcSEcCtD
Gadoteridol—Paraesthesia—Epirubicin—breast cancer	0.000377	0.000377	CcSEcCtD
Gadoteridol—Hyperhidrosis—Doxorubicin—breast cancer	0.000376	0.000376	CcSEcCtD
Gadoteridol—Dyspnoea—Epirubicin—breast cancer	0.000374	0.000374	CcSEcCtD
Gadoteridol—Nausea—Docetaxel—breast cancer	0.00037	0.00037	CcSEcCtD
Gadoteridol—Feeling abnormal—Methotrexate—breast cancer	0.00037	0.00037	CcSEcCtD
Gadoteridol—Hypotension—Doxorubicin—breast cancer	0.000363	0.000363	CcSEcCtD
Gadoteridol—Pain—Epirubicin—breast cancer	0.000359	0.000359	CcSEcCtD
Gadoteridol—Nausea—Capecitabine—breast cancer	0.000358	0.000358	CcSEcCtD
Gadoteridol—Urticaria—Methotrexate—breast cancer	0.000356	0.000356	CcSEcCtD
Gadoteridol—Abdominal pain—Methotrexate—breast cancer	0.000355	0.000355	CcSEcCtD
Gadoteridol—Body temperature increased—Methotrexate—breast cancer	0.000355	0.000355	CcSEcCtD
Gadoteridol—Paraesthesia—Doxorubicin—breast cancer	0.000349	0.000349	CcSEcCtD
Gadoteridol—Dyspnoea—Doxorubicin—breast cancer	0.000346	0.000346	CcSEcCtD
Gadoteridol—Feeling abnormal—Epirubicin—breast cancer	0.000346	0.000346	CcSEcCtD
Gadoteridol—Urticaria—Epirubicin—breast cancer	0.000334	0.000334	CcSEcCtD
Gadoteridol—Pain—Doxorubicin—breast cancer	0.000332	0.000332	CcSEcCtD
Gadoteridol—Abdominal pain—Epirubicin—breast cancer	0.000332	0.000332	CcSEcCtD
Gadoteridol—Body temperature increased—Epirubicin—breast cancer	0.000332	0.000332	CcSEcCtD
Gadoteridol—Hypersensitivity—Methotrexate—breast cancer	0.000331	0.000331	CcSEcCtD
Gadoteridol—Feeling abnormal—Doxorubicin—breast cancer	0.00032	0.00032	CcSEcCtD
Gadoteridol—Pruritus—Methotrexate—breast cancer	0.000317	0.000317	CcSEcCtD
Gadoteridol—Hypersensitivity—Epirubicin—breast cancer	0.000309	0.000309	CcSEcCtD
Gadoteridol—Urticaria—Doxorubicin—breast cancer	0.000309	0.000309	CcSEcCtD
Gadoteridol—Abdominal pain—Doxorubicin—breast cancer	0.000307	0.000307	CcSEcCtD
Gadoteridol—Body temperature increased—Doxorubicin—breast cancer	0.000307	0.000307	CcSEcCtD
Gadoteridol—Diarrhoea—Methotrexate—breast cancer	0.000307	0.000307	CcSEcCtD
Gadoteridol—Pruritus—Epirubicin—breast cancer	0.000297	0.000297	CcSEcCtD
Gadoteridol—Dizziness—Methotrexate—breast cancer	0.000297	0.000297	CcSEcCtD
Gadoteridol—Diarrhoea—Epirubicin—breast cancer	0.000287	0.000287	CcSEcCtD
Gadoteridol—Hypersensitivity—Doxorubicin—breast cancer	0.000286	0.000286	CcSEcCtD
Gadoteridol—Vomiting—Methotrexate—breast cancer	0.000285	0.000285	CcSEcCtD
Gadoteridol—Rash—Methotrexate—breast cancer	0.000283	0.000283	CcSEcCtD
Gadoteridol—Dermatitis—Methotrexate—breast cancer	0.000283	0.000283	CcSEcCtD
Gadoteridol—Headache—Methotrexate—breast cancer	0.000281	0.000281	CcSEcCtD
Gadoteridol—Dizziness—Epirubicin—breast cancer	0.000278	0.000278	CcSEcCtD
Gadoteridol—Pruritus—Doxorubicin—breast cancer	0.000275	0.000275	CcSEcCtD
Gadoteridol—Vomiting—Epirubicin—breast cancer	0.000267	0.000267	CcSEcCtD
Gadoteridol—Nausea—Methotrexate—breast cancer	0.000266	0.000266	CcSEcCtD
Gadoteridol—Diarrhoea—Doxorubicin—breast cancer	0.000266	0.000266	CcSEcCtD
Gadoteridol—Rash—Epirubicin—breast cancer	0.000265	0.000265	CcSEcCtD
Gadoteridol—Dermatitis—Epirubicin—breast cancer	0.000264	0.000264	CcSEcCtD
Gadoteridol—Headache—Epirubicin—breast cancer	0.000263	0.000263	CcSEcCtD
Gadoteridol—Dizziness—Doxorubicin—breast cancer	0.000257	0.000257	CcSEcCtD
Gadoteridol—Nausea—Epirubicin—breast cancer	0.000249	0.000249	CcSEcCtD
Gadoteridol—Vomiting—Doxorubicin—breast cancer	0.000247	0.000247	CcSEcCtD
Gadoteridol—Rash—Doxorubicin—breast cancer	0.000245	0.000245	CcSEcCtD
Gadoteridol—Dermatitis—Doxorubicin—breast cancer	0.000245	0.000245	CcSEcCtD
Gadoteridol—Headache—Doxorubicin—breast cancer	0.000243	0.000243	CcSEcCtD
Gadoteridol—Nausea—Doxorubicin—breast cancer	0.000231	0.000231	CcSEcCtD
